Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lamb Weston (LW)

Lamb Weston unit signs $103 million China term loan, refinancing 2022 facility

Neutral Impact 2 of 5 financing Written later

Lamb Weston's Chinese subsidiary, LW Ulanqab, entered into a RMB 700 million term loan facility with HSBC Bank (China) on May 19, 2026, maturing May 22, 2031. The loan repaid and replaced its 2022 facility, which was terminated May 22, 2026, and the parent company guarantees the obligations. The filing reports refinancing of existing debt rather than a new borrowing for other uses, and it does not disclose any earnings or guidance changes.

Key points

  • Term loan of RMB 700 million, about $102.94 million at the May 19, 2026 exchange rate, maturing May 22, 2031
  • Interest at the five-year prime rate published by the PRC National Interbank Funding Center plus 0.30%
  • Amortization payments begin 6 months after the initial borrowing, with the remaining principal due at maturity
  • The 2022 Facility Agreement dated February 18, 2022 was repaid and terminated on May 22, 2026

The filing

CompanyLamb Weston (LW)
Form8-K, current report
Filed with the SECMay 26, 2026, 11:36 AM ET
Accession number0001679273-26-000018

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.